Healthcare
from24/7 Wall St.
2 days agoIs Hims & Hers Really the Growth Stock to Buy That It Appears?
Hims & Hers resolved its legal crisis with Novo Nordisk by agreeing to sell branded GLP-1 drugs and discontinue most compounded versions, triggering a 64% stock surge.